Inventor · disambiguated record
Haiying Qin
Also filed as: QIN HAIYING
6 granted patents·3 pending applications·7 citations·filing 2014–2024
73Inventor score
Files withUS HEALTH7THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES1UNIV HANGZHOU DIANZI1
Top patents by PatentIndex Score
9 records- 0187US11980640B2Bicistronic chimeric antigen receptors and their usesUS HEALTH·Filed 2018·Granted May 14, 2024·3 cites·20 claims
- 0284US10738116B2Dual specific anti-CD22-anti-CD19 chimeric antigen receptorsTHE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2016·Granted Aug 11, 2020·3 cites·24 claims
- 0378US2025034244A1Bicistronic chimeric antigen receptors and their usesUS HEALTH·Filed 2024·Application pending·0 cites
- 0472US10676528B2Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using sameUS HEALTH·Filed 2014·Granted Jun 9, 2020·1 cites·22 claims
- 0563US11236171B2Human monoclonal antibodies specific for FLT3 and uses thereofUS HEALTH·Filed 2017·Granted Feb 1, 2022·0 cites·26 claims
- 0662US11834509B2Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using sameUS HEALTH·Filed 2020·Granted Dec 5, 2023·0 cites·22 claims
- 0748US10797333B2Preparation method for alkaline anion exchange membrane and use thereof in fuel cellUNIV HANGZHOU DIANZI·Filed 2016·Granted Oct 6, 2020·0 cites·8 claims
- 0846US2022127575A1Genetically modified hematopoietic stem and progenitor cells (hspcs) and mesenchymal cells as a platform to reduce or prevent metastasis, treat autoimmune and inflammatory disorders, and rebalance the immune milieu and dysregulated nichesUS HEALTH·Filed 2020·Application pending·0 cites
- 0945US2021017277A1Anti-cd33 chimeric antigen receptors and their usesUS HEALTH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haiying Qin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →